EnteroMedics (ETRM) Reports Q1 Loss of $1.27

EnteroMedics (NASDAQ: ETRM) reported Q1 EPS of ($1.27), versus ($0.94) reported last year. Revenue for the quarter came in at $40 thousand, versus $72 thousand reported last year.

On March 31, 2017, the Company\'s cash, cash equivalents and short-term investments totaled $18.7 million.

For earnings history and earnings-related data on EnteroMedics (ETRM) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c